Swansea University Medical School, ILS1 Building, Singleton Park, Swansea SA2 8PP, Wales, UK.
Department of Laboratory Medicine, Division of Clinical Chemistry, Karolinska University Hospital, Karolinska Institutet, 141 86 Huddinge, Sweden.
J Steroid Biochem Mol Biol. 2019 Dec;195:105475. doi: 10.1016/j.jsbmb.2019.105475. Epub 2019 Sep 18.
While the presence and abundance of the major oxysterols and cholestenoic acids in the circulation is well established, minor cholesterol metabolites may also have biological importance and be of value to investigate. In this study by observing the metabolism of deuterium-labelled cholesterol in the pdgfb mouse, a mouse model with increased vascular permeability in brain, and by studying the sterol content of plasma from the CYP46A1 transgenic mouse overexpressing the human cholesterol 24S-hydroxylase enzyme we have been able to identify a number of minor cholesterol metabolites found in the circulation, make approximate-quantitative measurements and postulate pathways for their formation. These "proof of principle" data may have relevance when using mouse models to mimic human disease and in respect of the increasing possibility of treating human neurodegenerative diseases with pharmaceuticals designed to enhance the activity of CYP46A1 or by adeno-associated virus delivery of CYP46A1.
虽然主要的氧化固醇和胆甾烯酸在循环中的存在和丰度已经得到很好的确证,但少量的胆固醇代谢物也可能具有重要的生物学意义,并值得研究。在这项研究中,通过观察 pdgfb 小鼠(一种脑血管通透性增加的小鼠模型)中氘标记胆固醇的代谢情况,以及研究过表达人类胆固醇 24S-羟化酶的 CYP46A1 转基因小鼠血浆中的甾醇含量,我们已经能够鉴定出一些在循环中发现的少量胆固醇代谢物,对其进行近似定量测量,并推测其形成途径。当使用小鼠模型模拟人类疾病时,以及当使用旨在增强 CYP46A1 活性的药物或通过腺相关病毒传递 CYP46A1 来治疗人类神经退行性疾病的可能性增加时,这些“原理证明”数据可能具有相关性。